SyVento BioTech will be joining Nordic Life Science Days 2026, taking place on 8-9 September at Kistamässan in Stockholm. Meet our team at the Polish National Pavilion, stand F:12, and explore how an integrated CDMO partner can help move your nucleic acid-based therapy from development toward GMP manufacturing and clinical supply.
Nordic Life Science Days is the largest life science partnering event in the Nordics, bringing together biotechnology and pharmaceutical companies, investors, innovators and decision-makers from across the international life science ecosystem.
For companies developing advanced therapeutics, it is an opportunity to turn promising conversations into concrete development and manufacturing partnerships.
From development challenges to a clear path toward the clinic
At SyVento BioTech, we support biotech and pharmaceutical companies developing innovative therapies, with particular expertise in mRNA, RNA-based therapeutics and lipid nanoparticle delivery technologies.
Meeting our team in Stockholm is an opportunity to discuss how we can help you:
- develop and optimize mRNA and nucleic acid manufacturing processes,
- develop and optimize LNP and lipid-based delivery systems,
- establish and validate analytical methods supporting product development and manufacturing,
- transfer and scale processes from laboratory development toward GMP manufacturing,
- manufacture GMP drug substance and clinical materials,
- provide aseptic Fill & Finish for clinical supply within an integrated GMP manufacturing environment,
- reduce the complexity of managing multiple development and manufacturing partners.
Our goal is not simply to provide individual services. We help our partners build a more integrated development path, connecting scientific expertise, process development, analytics, scale-up, GMP manufacturing and aseptic Fill & Finish within one organization.
For biotech companies preparing for Investigational New Drug (IND) applications in the US or Clinical Trial Applications (CTA) in Europe, clinical development or technology transfer, this can mean fewer handovers, better process continuity and a more efficient route from development to a finished, clinic-ready product.
By integrating drug substance development and manufacturing with GMP aseptic Fill & Finish, SyVento can help reduce one of the critical transition points between manufacturing and clinical supply. This integrated approach supports better process continuity, simplifies coordination between partners and helps development teams move toward clinical milestones with greater operational control.
Discover Polish life science innovation on the Spotlight Stage
SyVento will also take part in the Polish national presentation:
“Polish Life Science: Creativity, Innovation, Solidity”
Wednesday, 9 September 2026
10:15–10:45
dSpotlight Stage, located close to the Polish National Pavilion
The session will showcase the capabilities and growing international potential of the Polish life science ecosystem.
The presentation will feature Izabela Klockowska from BioForum and Kazimierz Murzyn representing the LifeScience Kraków Cluster, followed by short company presentations from five Polish companies participating in the National Pavilion:
- Dicella
- ExecMind Life Science Executive Search
- FiLeClo
- Mabion
- SyVento BioTech
Representing SyVento, Dominik Lipka, PhD, Eng will deliver a three-minute introduction to our capabilities and the role SyVento can play in advancing innovative therapeutic programs from development and scale-up through GMP manufacturing and aseptic Fill & Finish for clinical supply.
Meet SyVento at the Polish National Pavilion
If you are developing an mRNA, RNA, LNP or other advanced therapeutic program and are looking for a partner able to combine development expertise, GMP manufacturing and aseptic Fill & Finish within an integrated CDMO model, Nordic Life Science Days is a great opportunity to start the conversation.
Meet the SyVento BioTech team at:
Nordic Life Science Days 2026
8–9 September 2026
Kistamässan, Stockholm, Sweden
Polish National Pavilion – Stand F:12
Let’s discuss your development program, current manufacturing challenges and the next milestones on your path toward the clinic.
Meet us in Stockholm and discover how SyVento can help connect advanced science, GMP manufacturing and Fill & Finish in a more streamlined path to clinical supply.
